Trends in Anti-Influenza Drug Prescription and Adverse Drug Reaction Reporting After the Lifting of Oseltamivir Prescribing Restrictions in Pediatric Outpatients: An Ecological Study Using the MDV Analyzer® And the Japanese Adverse Drug Event Report Database

• Główni autorzy: Misaki Tokunaga (Autor), Daisuke Kikuchi (Autor), Aoi Noda (Autor), Sachiko Oikawa (Autor), Makoto Shiozawa (Autor), Hiroaki Hino (Autor), Ryosuke Miura (Autor), Kensuke Usui (Autor), Taku Obara (Autor), Kouji Okada (Autor)
• Format: Książka
• Wydane: Adis, Springer Healthcare, 2024-01-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Abstract Background Abnormal behavior after oseltamivir administration has been reported in the media; in 2007, the package insert for oseltamivir phosphate was revised to restrict its administration to individuals aged over 10 years. However, in 2018, the age limitation specified in the package ins...